Close Menu

NEW YORK (GenomeWeb) – GenMark Diagnostics said on Wednesday that it entered into a loan and security agreement on Feb. 1 through which Solar Capital is providing it with up to $65 million in a series of term loans.

In a filing with the US Securities and Exchange Commission, GenMark said that under the terms of the agreement, it had an option to borrow $50 million on Feb. 1 as part of a Tranche 1 Loan. It can borrow an additional $15 million no later than Dec. 31, 2019, should GenMark achieve a designated threshold amount of product revenues on a trailing six-month basis.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The nonprofit Biden Cancer Initiative is suspending its operations, according to the Associated Press.

Researchers examine how white nationalists handle personal genetic ancestry results that conflict with their racist worldview, the New York Times reports.

NPR speaks with research participants before and after they learn their APOE E4 status, which affects their risk of developing Alzheimer's disease.

In PLOS this week: genetic characterization of Toxoplasma gondii strains, Crimean-Congo Hemorrhagic Fever Virus uncovered in Sudan, and more.